Gaxos.ai (NASDAQ:GXAI – Get Free Report) and Concentra Group Holdings Parent (NYSE:CON – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.
Earnings & Valuation
This table compares Gaxos.ai and Concentra Group Holdings Parent”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Gaxos.ai | $6.01 million | 0.82 | -$3.90 million | ($0.50) | -0.92 |
| Concentra Group Holdings Parent | $2.16 billion | 2.22 | $166.41 million | $1.55 | 24.25 |
Volatility & Risk
Gaxos.ai has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, Concentra Group Holdings Parent has a beta of 0.63, meaning that its stock price is 37% less volatile than the S&P 500.
Insider and Institutional Ownership
42.6% of Gaxos.ai shares are held by institutional investors. 3.2% of Gaxos.ai shares are held by insiders. Comparatively, 8.1% of Concentra Group Holdings Parent shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Gaxos.ai and Concentra Group Holdings Parent’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Gaxos.ai | -64.81% | -38.79% | -36.99% |
| Concentra Group Holdings Parent | 8.69% | 47.81% | 7.04% |
Analyst Ratings
This is a summary of current ratings and price targets for Gaxos.ai and Concentra Group Holdings Parent, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Gaxos.ai | 1 | 0 | 0 | 0 | 1.00 |
| Concentra Group Holdings Parent | 0 | 0 | 7 | 1 | 3.12 |
Concentra Group Holdings Parent has a consensus target price of $39.40, suggesting a potential upside of 4.82%. Given Concentra Group Holdings Parent’s stronger consensus rating and higher probable upside, analysts plainly believe Concentra Group Holdings Parent is more favorable than Gaxos.ai.
Summary
Concentra Group Holdings Parent beats Gaxos.ai on 13 of the 15 factors compared between the two stocks.
About Gaxos.ai
Gaxos.ai Inc. engages in developing artificial intelligence applications for various sectors. Its portfolio includes applications in mental and physical wellbeing, coaching, and gaming. In addition, it offers Gaxos, a gaming platform develop, design, acquire, and manage conventional games and combine these games with unconventional game mechanisms. The company was formerly known as The NFT Gaming Company, Inc. and changed its name to Gaxos.ai Inc. in January 2024. Gaxos.ai Inc. was incorporated in 2021 and is based in Roseland, New Jersey.
About Concentra Group Holdings Parent
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers’ compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.
Receive News & Ratings for Gaxos.ai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gaxos.ai and related companies with MarketBeat.com's FREE daily email newsletter.
